NCT04906863 Genetic Studies of Early-onset Dementia
| NCT ID | NCT04906863 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Columbia University |
| Condition | Dementia, Early Onset |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2016-09-14 |
| Primary Completion | 2028-04-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000 participants in total. It began in 2016-09-14 with a primary completion date of 2028-04-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this study is to identify genetic factors that contribute to risk and progression of early-onset dementia (loss of memory function before the age of 70 years) across all ethnic groups, including Alzheimer's Disease, mild cognitive impairment and other dementias.
Eligibility Criteria
Inclusion criteria: * 35 years and older * Individuals experiencing memory concerns or diagnosed with dementia and their family members that are unrelated healthy controls without dementia. Exclusion Criteria: \- Individuals with competing diagnosis such as Huntington's disease, traumatic brain injury, drug or alcohol abuse, or schizophrenia, etc., unless family members of a dementia affected individual
Contact & Investigator
Christiane Reitz, MD, PhD
PRINCIPAL INVESTIGATOR
Columbia University
Frequently Asked Questions
Who can join the NCT04906863 clinical trial?
This trial is open to participants of all sexes, aged 35 Years or older, studying Dementia, Early Onset. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04906863 currently recruiting?
Yes, NCT04906863 is actively recruiting participants. Contact the research team at pd2727@cumc.columbia.edu for enrollment information.
Where is the NCT04906863 trial being conducted?
This trial is being conducted at New York, United States.
Who is sponsoring the NCT04906863 clinical trial?
NCT04906863 is sponsored by Columbia University. The principal investigator is Christiane Reitz, MD, PhD at Columbia University. The trial plans to enroll 1,000 participants.